Decaëns C, Rosa B, Bara J, Daher N, Burtin P
Carcinogenesis. 1983 Sep;4(9):1175-8. doi: 10.1093/carcin/4.9.1175.
The possible effect of oral 13 cis retinoic acid (13-cis-RA) on the carcinogenic process induced by 28 weekly s.c. injections of 1,2-dimethylhydrazine (DMH) in 34 Wistar rats was investigated. Using immunohistology, precancerous and cancerous stages were compared with the same stages induced by DMH without additional 13-cis-RA in 33 rats. M1 antigens, which characterize modifications in goblet-cell differentiation occurring early in rat colonic carcinogenesis, were used to investigate the possible effect of retinoids on differentiation during precancerous stages. From 3-20 weeks after the start of the experiment, no significant differences were observed in the timing of M1 antigens in the 2 groups of rats. It was also observed that 13-cis-RA had no effect on histological lesions associated with precancerous mucosa, nor on the occurrence of intestinal adenocarcinomas. Thus, under these conditions, oral administration of 13-cis-RA did not significantly inhibit precancerous or cancerous stages of intestinal carcinoma development.
研究了口服13-顺式维甲酸(13-cis-RA)对34只Wistar大鼠每周皮下注射28次1,2-二甲基肼(DMH)诱导的致癌过程的可能影响。采用免疫组织学方法,将33只大鼠中由DMH诱导且未额外使用13-cis-RA的癌前和癌变阶段与上述阶段进行比较。M1抗原可表征大鼠结肠癌发生早期杯状细胞分化的变化,用于研究类视黄醇在癌前阶段对分化的可能影响。实验开始后3至20周,两组大鼠M1抗原出现时间未观察到显著差异。还观察到13-cis-RA对与癌前黏膜相关的组织学病变以及肠腺癌的发生均无影响。因此,在这些条件下,口服13-cis-RA并未显著抑制肠道癌发生的癌前或癌变阶段。